Clinical Trials in Los Angeles

Showing 3861-3880 of 16,901 trials

Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy

NCT04403802

This is a double blind, randomized, crossover pilot study of Voxx Human Performance Technology Socks versus placebo socks for the treatment of chemotherapy-induced peripheral neuropathy in patients with cancer. Patients will be randomized 1:1 to one of the following regimens: * Arm A: Continuous wear of Voxx Human Performance Technology Socks for 2 weeks, followed by continuous wear of placebo socks for 2 weeks (separated by a 2-week washout period) * Arm B: Continuous wear of placebo socks for 2 weeks, followed by continuous wear of Voxx Human Performance Technology Socks for 2 weeks (separated by a 2-week washout period) Patients will be evaluated at three time points using an objective neuropathy assessment as well as self-report questionnaires assessing chemotherapy-induced peripheral neuropathy, quality of life, and cancer-related symptoms.

Neuropathy;PeripheralChemotherapy-induced Peripheral NeuropathyNeuropathy

Arash Asher, MD28 participantsStarted Oct 2020

Los Angeles, California, United States • Torrance, California, United States

COMPLETEDPhase 2< 1 mile

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

NCT04564027

The study is investigating efficacy, safety and tolerability of DNA-damage Response Agents (or Combinations), in participants with advanced/metastatic solid malignancies whose tumours contain molecular alterations

Advanced Solid Tumours

AstraZeneca54 participantsStarted Dec 2020

Duarte, California, United States • Los Angeles, California, United States • San Francisco, California, United States +15 more locations

Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Find Trials by Condition in Los Angeles

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Mitral Valve Screening Survey

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Long-Term Evaluation of BIIB067 (Tofersen)

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors